Taxol is the first of the taxanes, a new class of cytotoxic agents who
se cellular target is the microtubules network. Taxol induces the poly
merisation of the alpha and beta sub-units of the tubulin. This mechan
ism of action which is different from the vinca-alkaloids explains the
main cytotoxic activity of paclitaxel through the formation of abnorm
al and stable bundles of microtubules. Severe hypersensitivity reactio
ns which were seen in early phase I studies are prevented by an oral c
orticosteroids and H1 and H2 blockers premedication. Profound neutrope
nia is frequent but of short duration explaining that infectious manif
estations are rare and neutropenia not cumulative. Thrombopenia and an
emia are rare. Neurotoxicity is dose related but severe peripheral neu
ropathy is rare. Conduction abnormalities are mainly asymptomatic brad
ycardias. In second line ovarian cancer and breast metastatic cancer a
noticeable level of activity has been observed, and in lung and head
and neck cancer Taxol has proved to be effective.